Characterization of Endothelin-converting Enzyme-2
Open Access
- 1 April 2003
- journal article
- Published by Elsevier
- Vol. 278 (17) , 14704-14711
- https://doi.org/10.1074/jbc.m211242200
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Proprotein Convertases in Tumor Progression and Malignancy: Novel Targets in Cancer TherapyThe American Journal of Pathology, 2002
- Molecular isolation and characterization of novel four subisoforms of ECE-2Biochemical and Biophysical Research Communications, 2002
- Proenkephalin A gene products activate a new family of sensory neuron–specific GPCRsNature Neuroscience, 2002
- Processing of proSAAS in neuroendocrine cell linesBiochemical Journal, 2002
- Identification and Characterization of Novel Mammalian Neuropeptide FF-like Peptides That Attenuate Morphine-induced AntinociceptionJournal of Biological Chemistry, 2001
- The C-terminal Region of proSAAS Is a Potent Inhibitor of Prohormone Convertase 1Journal of Biological Chemistry, 2000
- Inhibitor Potencies and Substrate Preference for Endothelin-Converting Enzyme-1 are Dramatically Affected by PHJournal of Cardiovascular Pharmacology, 2000
- Proenkephalin-a-derived peptides are present in human brainLife Sciences, 1983
- A new family of endogenous “big” met-enkephalins from bovine adrenal medulla: purification and structure of docosa- (BAM-22P) and eicosapeptide (BAM-20P) with very potent opiate activityBiochemical and Biophysical Research Communications, 1980
- A new endogenous opioid peptide from bovine adrenal medulla: Isolation and amino acid sequence of a dodecapeptide (BAM-12P)Biochemical and Biophysical Research Communications, 1980